Treatment with α-PD-L1 NP demonstrated an immune profile suggestive of immune activation as indicated by higher frequencies of CD8+ T cells and B cells in the spleen, and tumor infiltrating inflammatory macrophages, neutrophils, and mature NK cells 49, 50. Here, CD8A is linked to neoplasm.